Literature DB >> 19657710

Primary hyperparathyroidism with breast carcinoma.

Yuko Tanaka1.   

Abstract

BACKGROUND: Although hypercalcemia is a common complication of breast carcinoma (BC), it may be due to primary hyperparathyroidism (pHPT), which has a similar sex or age predilection to that of BC. The rate of underlying asymptomatic pHPT in BC patients with hypercalcemia is exceptionally high, so the clinical data were retrospectively analyzed.
METHOD: To investigate coexistent pHPT in BC patients, the medical records of persons who had undergone surgery for primary BC without bone metastases between October 2004 and March 2008 at the Tsuchiura Kyodo General Hospital were retrospectively reviewed. The corrected serum calcium level was measured in all 243 patients. Ten patients who noted hypercalcemia above 11.0 mg/dl via the corrected serum calcium were selected in order to investigate pHPT. RESULT: Among the 243 patients investigated, 7 were diagnosed with pHPT, and 5 of those patients required surgical treatment. In all five patients, the parathyroids were pathologically diagnosed to have adenoma.
CONCLUSION: Primary hyperparathyroidism was diagnosed in 2.88% of the BC patients, which was more than expected, in comparison to the incidence of pHPT in adult women, which is 0.04-0.08%. It is important to assess whether pHPT is associated with the treatment of BC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19657710     DOI: 10.1007/s12282-009-0158-0

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  4 in total

1.  Hypercalcemia in metastatic breast cancer unrelated to skeletal metastasis.

Authors:  Heather Sigvaldason; Adebola Obayan; Ken von Kuster; K Alok Pathak
Journal:  CMAJ       Date:  2015-10-26       Impact factor: 8.262

2.  Prevention of breast cancer skeletal metastases with parathyroid hormone.

Authors:  Srilatha Swami; Joshua Johnson; Lance A Bettinson; Takaharu Kimura; Hui Zhu; Megan A Albertelli; Rachelle W Johnson; Joy Y Wu
Journal:  JCI Insight       Date:  2017-09-07

3.  PRIMARY HYPERPARATHYROIDISM AND SERUM CALCIUM IN BREAST CANCER PATIENTS EVALUATED FOR LOW BONE MASS - A SINGLE CENTER EXPERIENCE.

Authors:  Marija Punda; Petra Petranović Ovčariček; Anita Tabain; Klaas Pieter Koopmans; Gabriela Alfier; Tomislav Jukić; Ana Fröbe
Journal:  Acta Clin Croat       Date:  2021-12       Impact factor: 0.932

4.  Challenges of Differential Diagnosis Between Primary Hyperparathyroidism and Bone Metastases of Breast Cancer.

Authors:  Maksym Gorobeiko; Andrii Dinets; Denys Pominchuk; Karim Abdalla; Yuriy Prylutskyy; Viktoria Hoperia
Journal:  Clin Med Insights Case Rep       Date:  2022-09-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.